Top compounds associated with response to RP11-505K9.4


Feature Type Standardized
Nominal ANOVA
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.06 0.1
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.063 0.1
mRNA istradefylline CTRPv2 pan-cancer AAC 0.093 0.1
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA Zebularine CTRPv2 pan-cancer AAC -0.056 0.1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.059 0.1
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.051 0.1
mRNA neratinib CTRPv2 pan-cancer AAC 0.056 0.1
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.081 0.1
Download CSV